ICML 2023 | 10-year follow-up of the LNH03-6B trial: outcomes of older patients with DLBCL treated with R-CHOP
Vincent Camus
• 14 Jun 2023
In this video, Vincent Camus, MD, University of Rouen, Rouen, France, shares some insights into the Phase III LNH03-6B trial (NCT00144755), which compared the safety and efficacy of R-CHOP given every 14 days compared to R-CHOP given every 21 days in elderly patients with diffuse large B-cell lymphoma (DLBCL). Dr Camus highlights the progression-free and overall survival (PFS; OS) at 10 years, and further discusses the relapse patterns observed in this patient population. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
